These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34830956)

  • 41. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Importance of Cancer-Associated Fibroblasts in the Pathogenesis of Head and Neck Cancers.
    Raudenská M; Svobodová M; Gumulec J; Falk M; Masařík M
    Klin Onkol; 2020; 33(1):39-48. PubMed ID: 32075388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells.
    Clayton SM; Archard JA; Wagner J; Farwell DG; Bewley AF; Beliveau A; Birkeland A; Rao S; Abouyared M; Belafsky PC; Anderson JD
    Stem Cells Dev; 2020 Mar; 29(6):327-335. PubMed ID: 31856674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.
    Wheeler SE; Shi H; Lin F; Dasari S; Bednash J; Thorne S; Watkins S; Joshi R; Thomas SM
    Head Neck; 2014 Mar; 36(3):385-92. PubMed ID: 23728942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy.
    Xie F; Zhou X; Fang M; Li H; Su P; Tu Y; Zhang L; Zhou F
    Adv Sci (Weinh); 2019 Dec; 6(24):1901779. PubMed ID: 31871860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor microenvironment is not an 'innocent bystander' in the resistance to treatment of head and neck cancers (Review).
    Mazilu L; Suceveanu AI; Stanculeanu DL; Gheorghe AD; Fricatel G; Negru SM
    Exp Ther Med; 2021 Oct; 22(4):1128. PubMed ID: 34466142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different Aspects of Head and Neck Squamous Cell Carcinoma: Cancer Stem Cells, their Niche and Targeted Therapy.
    Küçükgüven MB; Çelebi-Saltik B
    Curr Stem Cell Res Ther; 2021; 16(3):286-306. PubMed ID: 32957904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma.
    Qin Y; Zheng X; Gao W; Wang B; Wu Y
    Mol Ther Oncolytics; 2021 Mar; 20():342-351. PubMed ID: 33614915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
    Cohen EEW; Bell RB; Bifulco CB; Burtness B; Gillison ML; Harrington KJ; Le QT; Lee NY; Leidner R; Lewis RL; Licitra L; Mehanna H; Mell LK; Raben A; Sikora AG; Uppaluri R; Whitworth F; Zandberg DP; Ferris RL
    J Immunother Cancer; 2019 Jul; 7(1):184. PubMed ID: 31307547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-204-5p is a tumor suppressor and potential therapeutic target in head and neck squamous cell carcinoma.
    Zhuang Z; Yu P; Xie N; Wu Y; Liu H; Zhang M; Tao Y; Wang W; Yin H; Zou B; Hou J; Liu X; Li J; Huang H; Wang C
    Theranostics; 2020; 10(3):1433-1453. PubMed ID: 31938073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exosomes and other extracellular vesicles in oral and salivary gland cancers.
    Zhan C; Yang X; Yin X; Hou J
    Oral Dis; 2020 Jul; 26(5):865-875. PubMed ID: 31390111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.